What are the treatment options for facial alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Facial Alopecia

For facial alopecia, intralesional corticosteroid injections are the most effective first-line treatment, particularly for limited patchy hair loss in cosmetically sensitive areas such as eyebrows. 1

Treatment Algorithm Based on Pattern of Hair Loss

Limited Patchy Facial Alopecia

  • Intralesional corticosteroids are the treatment of choice for limited patchy facial alopecia, with evidence supporting their efficacy 1
  • Hydrocortisone acetate (25 mg/mL) or triamcinolone acetonide (5-10 mg/mL) can be injected just beneath the dermis in the upper subcutis 1
  • An injection of 0.05-0.1 mL will produce a tuft of hair growth about 0.5 cm in diameter 1
  • Response rates of up to 62% have been reported with monthly injections of triamcinolone acetonide 1

Eyebrow Alopecia

  • Intralesional corticosteroids are particularly suitable for cosmetically sensitive sites like eyebrows 1
  • Prostaglandin F2α analogues (latanoprost, bimatoprost) may be considered for eyelash alopecia, with one study showing 45% of patients achieved complete or moderate regrowth of eyelashes when treated with topical latanoprost for 2 years 1

Extensive Facial Alopecia

  • Contact immunotherapy is recommended for extensive patchy hair loss 1
  • The protocol involves sensitization with 2% solution of diphenylcyclopropenone (DPCP) followed by weekly applications of increasing concentrations until a mild dermatitis reaction is obtained 1
  • This treatment requires multiple hospital visits over several months and stimulates cosmetically worthwhile hair regrowth in <50% of patients 1

Second-Line Treatment Options

  • Topical minoxidil (1-5%):

    • Has been used for alopecia areata with mixed results 1
    • Early studies showed some efficacy, but subsequent controlled trials reported response rates of only 32-33% 1
    • Limited evidence for sustained benefit in facial alopecia 2, 3
  • Dithranol (anthralin):

    • Limited evidence for efficacy in facial alopecia 1
    • Only about 18% of patients with extensive alopecia areata achieve cosmetically worthwhile hair regrowth 1
    • Must be applied frequently and in high enough concentration to produce a brisk irritant reaction 1
    • Staining of hair limits its use in fair-haired individuals 1

Systemic Options for Refractory Cases

  • Methotrexate (15-25 mg per week):

    • May be considered in severe cases unresponsive to other treatments 1
    • A retrospective review showed 14 of 22 patients with alopecia totalis/universalis achieved complete regrowth 1
  • Sulfasalazine:

    • Some evidence of efficacy in uncontrolled studies 1
    • In one study of 26 patients with severe alopecia areata, 15 showed partial or complete recovery, though 10 later relapsed 1
  • Ciclosporin:

    • Has immunosuppressive and hypertrichotic properties 1
    • Evidence suggests it can stimulate hair regrowth in some patients 1
    • Side effects are a major consideration, and the cosmetically worthwhile response rate may be too low to justify the risks 1

Important Considerations and Caveats

  • The tendency for spontaneous remission in alopecia areata means that not treating is sometimes the best option 1

  • Treatment selection should be guided by:

    • Extent of hair loss (patchy vs. extensive) 1
    • Location (eyebrows, beard, scalp) 1
    • Duration of disease 1
  • Common pitfalls to avoid:

    • Continuous or pulsed systemic corticosteroids and PUVA have been used but cannot be recommended due to potentially serious side effects and inadequate evidence of efficacy 1
    • Topical tacrolimus showed no response in a case series of 11 patients with moderate to severe alopecia areata treated for 24 weeks 1
    • Treatments that were ineffective in controlled trials include oral zinc and isoprinosine 1
  • For patients with extensive facial alopecia where treatments are ineffective, cosmetic camouflage may be the most practical solution 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Off-Label Use of Topical Minoxidil in Alopecia: A Review.

American journal of clinical dermatology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.